COPD Exacerbation Clinical Trial
Official title:
FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation
NCT number | NCT03396172 |
Other study ID # | 21419 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 24, 2018 |
Est. completion date | December 2025 |
The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation. The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 2025 |
Est. primary completion date | June 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: All patients hospitalized for COPD exacerbation for less than 48 hours will be considered. - known or suspected COPD to entry - Age > or = 40 years - Ex-smoker history (10 pack / year or more) - Acute Exacerbation: dyspnea of recent onset (less than 15 days) - The need for oxygen therapy with a moderate rate: <6L / min to maintain SpO2 > 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home) Exclusion Criteria: - Refusal to consent to participate in the study, - Indication for an imminent intubation according to the pulmonologist, - Sleep Apnea - NIV used at home - Lack of FreeO2 system available at the time of randomization - Non-autonomous and alone at home - Patient alone at home - Patients who live more than 50 km from the hospital - Patient already included in the study within 3 months |
Country | Name | City | State |
---|---|---|---|
Canada | Institut Universitaire de Cardiologie et de Pneumologie de Québec | Quebec |
Lead Sponsor | Collaborator |
---|---|
Laval University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of hospital days during COPD exacerbation at day 30. | The objective of the study is to reduced the hospitalisation days by 50 % at day 30 during COPD exacerbation | 30 days | |
Secondary | Rate of Emergency consultation and hospital readmission | Rate of Emergency consultation and hospital readmission | 1 and 3 months | |
Secondary | Health Related Quality of Life | Survey of health related quality of life | 1 and 3 months | |
Secondary | Cost of care at 3 months | Economic evaluation about these 2 different strategy of COPD exacerbation management using micro-costing approach and including the cost of the FreeO2 technology | 3 months | |
Secondary | Oxygenation data (% of time in the SpO2 target, % of time with hypoxemia, % of time with hyperoxia) | The continuous measurement of SpO2 and O2 flow rate with the FreeO2 device (only in the FreeDom strategy) will allow the calculation of the % of time within the SpO2 target (recorded in the FreeO2) ± 2%, with hypoxemia (% of time with SpO2 < 85%) and with hyperoxia (% of time above SpO2 target +5%) | From inclusion to hospital discharge and from hospital discharge to the end of oxygen therapy (around one week after discharge) | |
Secondary | Number of consultations | Number of consultation : phone call, video consultation, rehabilitation, home visit | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06000696 -
Healthy at Home Pilot
|
||
Recruiting |
NCT03250000 -
Changes in Microcirculation and Functional Status During Exacerbation of COPD
|
N/A | |
Recruiting |
NCT04142827 -
The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)
|
N/A | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT01892566 -
Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
|
N/A | |
Completed |
NCT04119856 -
Outgoing Lung Team - a Cross-sectorial Intervention in Patients With COPD
|
N/A | |
Recruiting |
NCT06118632 -
Physiological and Environmental Data in a Remote Setting to Predict Exacerbation Events in Patients With Chronic Obstructive Pulmonary Disease
|
||
Recruiting |
NCT04860375 -
Multidisciplinary Management of Severe COPD
|
N/A | |
Completed |
NCT04170361 -
The Effect of Incentive Spirometry Added to Routine Physiotherapy Program on Hemodynamic Responses and Hospital Stay in Patients With COPD Exacerbation
|
N/A | |
Not yet recruiting |
NCT03696563 -
FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS
|
N/A | |
Not yet recruiting |
NCT03296215 -
Pattern of Admitted Cases in Respiratory Intensive Care Unit at Assiut University Hospitals
|
N/A | |
Completed |
NCT02912689 -
NIV - NAVA vs NIV - PS for COPD Exacerbation
|
N/A | |
Completed |
NCT03003702 -
Domiciliary Monitoring to Predict Exacerbations of COPD
|
N/A | |
Recruiting |
NCT02264483 -
Low-dose CT for Diagnosis of Pneumonia in COPD Exacerbations and Comparison of the Inflammatory Profile.
|
N/A | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Recruiting |
NCT02065921 -
Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort
|
||
Completed |
NCT04880486 -
Weight Training With VR in Out-Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
|
N/A | |
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|
||
Recruiting |
NCT04638920 -
Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy
|
||
Not yet recruiting |
NCT05897125 -
Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients
|
N/A |